Associate Professor Hisao Yoshikawa was born in Osaka. He obtained a bachelor and master degree of Biology in Kobe and then moved to a Ph.D. course as a student in Medical Zoology, equivalent to Parasitology, in Kyoto Prefectural University of Medicine, where he worked on Pneumocystis carinii, especially ultrastructure of this unclassified microbe at that time. He was skillful for freeze-fracture and immune-electron microscopy, and his expertise had contributed to the development of Hitachi freeze-fracture apparatus FR-7000. After he moved to Nara Women’s University, he focused on Blastocystis research, especially for morphology, epidemiology, and molecular phylogeny. While there, he temporarily moved in Dr. Don Graves laboratory, University of Oklahoma for the collaborated research on Pneumocystis carinii under the NIN grant for one year. He has published about 90 articles and four book chapters including editor, most of which are peer-reviewed. He will be retiring at the end of March this year.

Dr. John Anthony YASON finished his PhD from Yong Loo Lin School of Medicine, National University of Singapore. He was also a Postdoctoral Research Fellow at the Laboratory of Molecular and Cellular Parasitology, Department of Microbiology and Immunology in the same University under the supervision of Assoc. Professor Kevin SW TAN. He focused his research on Blastocystis and later on studied its interactions with host cells and gut microbiota. He has previously worked on protistan parasites and currently doing epidemiological surveys on pathogens linked to neglected tropical diseases. He was also a consultant for COVID-19 Diagnostic Lab in the Philippines. He is currently the Dean of the Institute of Health Sciences and Nursing and teaches Advanced Microbiology and Research Methods courses at Far Eastern University in Manila, the Philippines.

Dr. Jonathan Lee is an early-career clinician scientist at National University of Singapore (NUS) Medicine, a principal investigator at iHealthTech, with a special interest in the field of Microbiome Medicine, as well as consultant Gastroenterology at National University Hospital (NUH), Singapore. He completed his Masters of Clinical Investigations, funded by the NMRC-MOH healthware award to study the mucosal microbiome profiles in patients with non-alcoholic fatty liver disease. He was then awarded the NRMC research fellowship from 2019-2021 to study host-microbita interactions in gastrointestinal diseases at the Broad Institute MIT-Harvard, under Professor Ramnik Xavier. Dr Lee also currently leads the NUH fecal microbiome transplant programme, and have multiple ongoing studies collecting fecal microbial samples from both healthy patients and patients with gastrointestinal diseases.

Prof van der Giezen's research focuses mainly on intestinal microbiology and mitochondrial adaptations to anoxia as found in the animal gut. The topic of his PhD at the University of Groningen (the Netherlands) and his subsequent postdoc at the Natural History Museum (London, UK) was hydrogenosomes (unusual mitochondria) from anaerobic fungi. During his postdoc at Royal Holloway, University of London (UK), where he was involved in the discovery of mitosomes in Giardia, the topic shifted to human gut parasites (Entamoeba and Giardia). During his lectureship (~Assistant Professor) at Queen Mary, University of London (UK), he first worked with Blastocystis when he started a collaboration with Graham Clark. In 2007, he moved to the University of Exeter (UK) as a Senior Lecturer and became Associate Professor of Evolutionary Biochemistry. At Exeter, his work shifted partly to animal parasitology and the role of the microbiome in animal health. Since summer 2019, he is the Professor of Biological Chemistry at the University of Stavanger in Norway. Here he continues his research on important parasites for humans and animals and have established close research links with the academic hospital in Stavanger.

Professor Pettersson, MD. PhD and internationally renowned investigator with a string of high-profile publications in the area of gut microbe body function including how gut microbes and their metabolites regulate brain development and function. Currently, he is appointed at the National Neuroscience Institute (NNI) as Senior PI and affiliated as Professor at NUS. Since 2015 he is elected as a member of the Canadian Institute for Advanced Research (CIFAR) with a focus on the human microbiome and human health. In 2020, the Jeffrey Cheah foundation. Malaysia awarded him a grant to establish an ASEAN Microbiome Nutrition Centre (AMNC) jointly between NNI and Sunway University Malaysia. The focus of the Centre is to study gut-brain communication relevant to neurodegenerative diseases including the role of gut microbes, ageing and Parkinson's disease.

Dr. Benoit received his PhD in Immunology at the Alternative Energies and Atomic Energy Commission (CEA) in Paris, France. During his PhD, he worked on non-human primate models, and studied the innate response of macaques to Simian Immunodeficiency Virus (SIV) infection. He subsequently moved from Paris to Singapore to take up a post-doctoral research position to study malaria parasites and host cell tropism at the Singapore Immunology Network (SIgN), A*STAR. In 2018, Benoit became an Assistant Professor in the Department of Microbiology and Immunology and his lab focuses on erythrocytic immunobiology and host-microbiome interactions in the gut. He has published over 80 articles with over 5,000 citations. He was awarded the 2020 Yong Loo Lin School of Medicine Young Researcher of the Year Award. He is also Director of Electron Microscopy Unit in NUS Yong Loo Lin School of Medicine and Principal Investigator in SIgN, A*STAR .

Dr Png Chin Wen received his PhD in the field of Medicine from the University of Queensland (Australia) and has since focused his research on gut mucosal inflammation, gastrointestinal cancers, and the gut microbiome. Currently, he is a lecturer at NUS and has continued his research to understand the signalling mechanisms involved in colorectal cancer pathogenesis, with a particular emphasis on a group of molecules known as dual specificity phosphatases (DUSPs). At the same time, he has ongoing collaborations with clinicians to investigate the changes in gut microbiome and explore the functional role of gut bacteria that are crucial in disease development.

Mr. Steven Santino LEONARDI is a PhD candidate at the Laboratory of Molecular and Cellular Parasitology (Yong Loo Lin School of Medicine, NUS) under the supervision of Assoc. Prof. Kevin SW Tan. He received his Honour’s degree in Biomedical Science from the University of Queensland, Australia, and has interned with A*STAR’s Epithelial Biology Lab multiple times under Prof. Birgit Lane. He is experienced in tissue culture, and has previously worked on the STMND1 protein, the p75NTR/TrkA interaction, and Epidermolysis Bullosa Simplex drug screening in an in vitro setting. He is currently investigating the effect of Blastocystis’s tryptophan-producing BhTnaA enzyme on downstream neuromodulatory metabolite synthesis by host cells in the gut and liver.